Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Immediate risk of transmission to the American public is still low, according to experts.
Although this is a serious public health threat, the CDC says the immediate risk to the American public is low.
A recent mid-stage trial that combined coblopasvir with Sovaldi (sofosbuvir) boasted a high cure rate.
Chinese health officials say the strain of the virus, previously found only in rats, is a wake-up call for Hong Kong.
Do rodents in crowded cities pose a new risk for the liver virus?
But only a small fraction of those living with the virus worldwide have been cured.
These rates are driven in large part by hepatitis B and C.
The Nobel Peace Prize winner had a history of hepatitis B.
A potent new opiate called carfentanil has hit the U.S. drug supply and is driving up overdoses across the country.
A rare move by the country may help open up treatment access to nearly 10 million HCV-positive people in China.
Chinese health authorities have yet to approve new HCV treatments, fueling a medical tourism industry worth up to $50 billion.
The country will account for nearly half of the world’s total drug sales for the liver disease by 2024.
I had an interesting phone call from an Australian doctor, a GP, who has been prescribing Chinese Daclatavir+Sofosbuvi
Advocates say the decision could lead the way for more countries to nix protections over the expensive liver disease treatment.
The shot can provide protection from the liver virus for at least four and a half years.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.